The open-label, multi-part Phase II trial will assess RCT2100’s biodistribution, safety, and tolerability via oral inhalation ...

Everest Medicines has dosed the first participant in a Phase I clinical trial of its tumour-associated antigen (TAA) cancer ...

This report describes and explains the RNA targeting small molecules therapeutics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report ...

AVJ16 – has blocked the cancer-driving RNA-binding protein IGF2BP1 in preclinical lung cancer models, curbing tumour growth while sparing healthy tissue, in ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer ...

Key opportunities in the RNA targeting small molecules therapeutics market include growth in RNA splicing modifications, neurodegenerative diseases, drug discovery, and pharma-biotech sectors.

South Korean gene-editing company ToolGen has secured a patent in the United States, the world's largest biotech market, for ...

In recent years, the direction of the Nobel Prizes in science has become increasingly clear: it is technology that builds the runway toward the ...

The remarkably preserved mammoth has pushed the known limits of RNA survival, offering rare insights into the real-time ...

Following a gift from Brown trustee Giammaria Giuliani P’28 and Sabrina Giuliani P’28, Brown’s RNA center will be named the ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Friday, November 07, 2025. Let’s ...